Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chasteberry-based herbal medicine vs dydrogesterone in PCOS
IRCT20251224068427N1Phase 3Recruiting
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dydrogesterone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Apr 2026; status: recruiting.
02
Drugs
dydrogesterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20251224068427N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251224068427N1.